Literature DB >> 32311362

Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot.

Tommaso Lorenzo Parigi1, Ferdinando D'Amico2, Silvio Danese3.   

Abstract

Entities:  

Year:  2020        PMID： 32311362     DOI： 10.1053/j.gastro.2020.04.034

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center.

Authors:  Cindy Traboulsi; Fares Ayoub; Alexa Silfen; Tina G Rodriguez; David T Rubin
Journal:  Dig Dis Sci       Date:  2022-06-13       Impact factor: 3.199

2.  IBD therapeutics: what is in the pipeline?

Authors:  Alexandros Toskas; Ayesha Akbar
Journal:  Frontline Gastroenterol       Date:  2022-06-15

Review 3.  The Gut Microbiota in Inflammatory Bowel Disease.

Authors:  Peng Qiu; Takatsugu Ishimoto; Lingfeng Fu; Jun Zhang; Zhenyong Zhang; Yang Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.